InvestorsHub Logo
Followers 6
Posts 136
Boards Moderated 0
Alias Born 05/08/2014

Re: TOB post# 14030

Friday, 06/20/2014 1:54:40 PM

Friday, June 20, 2014 1:54:40 PM

Post# of 710049
Hi TOB, the 2nd statement made by MD Anderson from Jim is very neutral, IMO. It states the same thing that Linda has been communicating via her PRs, just in a bunch of different words.

I think it is logically leap to say that MD Anderson "validated" the doctor's words AND is rebuking NWBO also. In reality, it is just saying that the ongoing trial data is not a representative conclusion and can still change.

From what you wrote, it appears to me that you are using Jim's words to validate the Doctor's. I believe, Jim was just re-iterating the fact that MD Anderson does not believe this trial has provided anything conclusive. Jim never said that the data shouldn't be shared, just that it is not conclusive.

Now ... the weight of the Doctor's opinion is a different story. Just because you hold a VP position does not mean that he is well versed in all of the current ongoing clinical trials. Nor does this mean he wrote the current handbook of policies that governs how open phase I/II data from MD Anderson should be shared. He might not even be part of the process of approving any part of trials that relate to sharing data. Not saying his opinion is not worth something, but just saying that there is still a large range of variables to consider and placing his opinion on a pedestal. One of those variables is his responsibilities in the processes that govern a clinical trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News